Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders
Schizophrenia Research · 2024
DOI: 10.1016/j.schres.2024.03.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Y Nina Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Vagelos College of Physicians & Surgeons Columbia University and New York State Psychiatric Institute, New York, United Sta…. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Patient Readmission, Psychotic Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, New York State Office of Mental Health, Leon Levy Foundation.
Abstract (Originalsprache)
OBJECTIVE: To describe patterns of antipsychotic switching among patients hospitalized for schizophrenia and to correlate antipsychotic switching with hospital readmission risk. METHODS: We identified 3295 patients with index hospitalizations for schizophrenia or schizoaffective disorder from New York State Medicaid claims 2017-2018 who had filled at least one prescription for an antipsychotic in both the 44 days (one month +14 day grace period) prior to and after their admission. We identified patients who had kept or switched any of their antipsychotic medication between the pre- and post-periods surrounding their index hospitalization. We compared the kept and switched any groups, adjusting for patient characteristics. RESULTS: Of patients who had filled antipsychotic prescriptions in both the 44 days prior to and after their hospitalization, 1599 (48.6 %) had switched at least one antipsychotic and 1215 (36.8 %) had switched their primary antipsychotic. Switching any antipsychotic was associated with increased hazards of readmission, HR = 1.21, 95%CI 1.09-1.35, which was slightly concentrated during the first 90 days after hospital discharge. CONCLUSIONS: Switching antipsychotic medications during hospitalization occurs commonly and is associated with higher rehospitalization risk following hospital discharge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Vagelos College of Physicians & Surgeons Columbia University and New York State Psychiatric Institute, New York, United States of America. Electronic address: yihe.gao@nyspi.columbia.edu.
- New York State Office of Mental Health, Albany, New York, United States of America.
- Departments of Psychiatry and Epidemiology, Columbia University, New York and New York State Psychiatric Institute, New York, United States of America.
Förderung
- NIMH NIH HHS
- New York State Office of Mental Health
- Leon Levy Foundation
- National Institute of Mental Health
Zitieren
APA
Gao, Y. N., Wang, R., Gu, G., Chung, R., & Olfson, M. (2024). Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.03.034
Vancouver
Gao YN, Wang R, Gu G, Chung R, Olfson M. Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.03.034
BibTeX
@article{Gao2024,
author = {Gao, Y Nina and Wang, Rui and Gu, Gyojeong and Chung, Rakkoo and Olfson, Mark},
title = {Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders},
journal = {Schizophrenia Research},
year = {2024},
doi = {10.1016/j.schres.2024.03.034}
}
EUVIMED